7月25日,南京江北新区生物医药谷园区企业南京维立志博生物科技股份有限公司在港交所主板成功挂牌上市,股份代号:09887,预计募集资金总额可达1.89亿美元(含绿鞋)。这也是今年南京江北新区第二家上市企业。作为一家处于临床阶段的生物科技公司,维立志博于2012年成立,十余年来,团队始终专注于肿瘤、自身免疫性疾病及其他重大疾病新疗法的发现、开发及商业化。如今,公司已拥有涵盖14款创新候选药物的多元化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.